Aurinia Pharmaceuticals Sees FY2026 Sales $315.000M-$325.000M vs $326.858M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Aurinia Pharmaceuticals (NASDAQ:AUPH) sees FY2026 sales of $315.000 million-$325.000 million vs $326.858 million analyst estimate.
Aurinia Pharmaceuticals (NASDAQ:AUPH) sees FY2026 sales of $315.000 million-$325.000 million vs $326.858 million analyst estimate.